These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 8162656)

  • 1. Pharmacokinetic characterisation of transdermal delivery systems.
    Berner B; John VA
    Clin Pharmacokinet; 1994 Feb; 26(2):121-34. PubMed ID: 8162656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic considerations in the use of newer transdermal formulations.
    Ridout G; Santus GC; Guy RH
    Clin Pharmacokinet; 1988 Aug; 15(2):114-31. PubMed ID: 3064951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transdermal drug delivery and cutaneous metabolism.
    Guy RH; Hadgraft J; Bucks DA
    Xenobiotica; 1987 Mar; 17(3):325-43. PubMed ID: 3107225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal delivery: product and patent update.
    Gupta H; Babu RJ
    Recent Pat Drug Deliv Formul; 2013 Dec; 7(3):184-205. PubMed ID: 24025130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin sensitivity and transdermal drug delivery. A review of the problem.
    Carmichael AJ
    Drug Saf; 1994 Feb; 10(2):151-9. PubMed ID: 8011180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Management of transdermal therapeutics in perioperative care].
    Gentile A; Tran-Van D; Dardare E; Fritsch N; Benois A; Fontaine B
    Ann Fr Anesth Reanim; 2009 Apr; 28(4):311-20. PubMed ID: 19304449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transdermal drug delivery systems and skin sensitivity reactions. Incidence and management.
    Murphy M; Carmichael AJ
    Am J Clin Dermatol; 2000; 1(6):361-8. PubMed ID: 11702612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin hypersensitivity reactions to transdermal therapeutic systems--still an important clinical problem.
    Jenerowicz D; Polańska A; Olek-Hrab K; Silny W
    Ginekol Pol; 2012 Jan; 83(1):46-50. PubMed ID: 22384639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdermal drug pharmacokinetics in man: Interindividual variability and partial prediction.
    Farahmand S; Maibach HI
    Int J Pharm; 2009 Feb; 367(1-2):1-15. PubMed ID: 19100821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal delivery of contraceptives.
    Friend DR
    Crit Rev Ther Drug Carrier Syst; 1990; 7(2):149-86. PubMed ID: 2272099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of steady state development and reduction of menopausal symptoms after oral or transdermal delivery of 17-β-estradiol in young healthy symptomatic menopausal women.
    Rohr UD; Volko CD; Schindler AE
    Horm Mol Biol Clin Investig; 2014 Jun; 18(3):123-36. PubMed ID: 25390008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men.
    Swerdloff RS; Wang C; Cunningham G; Dobs A; Iranmanesh A; Matsumoto AM; Snyder PJ; Weber T; Longstreth J; Berman N
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4500-10. PubMed ID: 11134099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacokinetics of glyceryl trinitrate following the use of systemic and topical preparations.
    Bogaert MG
    Clin Pharmacokinet; 1987 Jan; 12(1):1-11. PubMed ID: 3102143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic systems and drug delivery. 3. Transdermal therapeutic systems].
    Davila D; Karleusa-Simanović A; Davila T
    Lijec Vjesn; 1990; 112(7-8):235-43. PubMed ID: 2292898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Permeation enhancer strategies in transdermal drug delivery.
    Marwah H; Garg T; Goyal AK; Rath G
    Drug Deliv; 2016; 23(2):564-78. PubMed ID: 25006687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioavailability and pharmacokinetic profile of glyceryl trinitrate and of glyceryl dinitrates during application of a new glyceryl trinitrate transdermal patch.
    Santoro A; Rovati LC; Setnikar I; Caplain H; Gualano V
    Arzneimittelforschung; 2000 Sep; 50(9):779-85. PubMed ID: 11050693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The transdermal delivery of fentanyl.
    Lane ME
    Eur J Pharm Biopharm; 2013 Aug; 84(3):449-55. PubMed ID: 23419814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A commentary on transdermal drug delivery systems in clinical trials.
    Watkinson AC
    J Pharm Sci; 2013 Sep; 102(9):3082-8. PubMed ID: 23468246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Transdermal therapeutic systems for drug administration].
    Hupfeld S; Gravem H
    Tidsskr Nor Laegeforen; 2009 Mar; 129(6):532-3. PubMed ID: 19282891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steady-state pharmacokinetics and dose relationship of nicotine delivered from Nicoderm (Nicotine Transdermal System).
    Gorsline J; Gupta SK; Dye D; Rolf CN
    J Clin Pharmacol; 1993 Feb; 33(2):161-8. PubMed ID: 8440766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.